Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-04-039317
Filing Date
2004-12-13
Accepted
2004-12-13 16:22:57
Documents
8
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 10-K a04-14551_110k.htm 10-K 561813
2 EX-10.1 a04-14551_1ex10d1.htm EX-10.1 55500
3 EX-10.35 a04-14551_1ex10d35.htm EX-10.35 72822
4 EX-13.1 a04-14551_1ex13d1.htm EX-13.1 1804719
5 EX-23.1 a04-14551_1ex23d1.htm EX-23.1 5572
6 EX-31.1 a04-14551_1ex31d1.htm EX-31.1 12765
7 EX-31.2 a04-14551_1ex31d2.htm EX-31.2 12742
8 EX-32 a04-14551_1ex32.htm EX-32 8559
  Complete submission text file 0001104659-04-039317.txt   2536871
Mailing Address 8899 UNIVERSITY CENTER LANE STE 400 SAN DIEGO CA 92122
Business Address 8899 UNIVERSITY CTR LANE STE 400 SAN DIEGO CA 92122 8584534040
MAXIM PHARMACEUTICALS INC (Filer) CIK: 0001013351 (see all company filings)

EIN.: 870279983 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-14430 | Film No.: 041199043
SIC: 2833 Medicinal Chemicals & Botanical Products